Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 17-Jun-24 7:30 AM View:  | Donhauser Peter D.O. Director | Anavex Life Sciences Corp. (AVXL) | 14-Jun-24 | Private Purchase | 2,835 | $3.64 | $10,319.40 | 131% 2.17K to 5.0K | |
| 17-May-24 6:01 AM View: | Thomas Steffen Director | Anavex Life Sciences Corp. (AVXL) | 15-May-24 | Private Purchase | 5,000 | $4.52 | $22,600.00 | 100% 0 to 5.0K | |
| 01-Apr-24 6:00 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 28-Mar-24 | Option Sale | 73,380 | $5.11 | $374,972.00 | (6%) 1.32M to 1.25M | |
| 01-Apr-24 6:00 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 28-Mar-24 | Option Exercise | 73,380 | $1.32 | $96,861.60 | 6% 1.25M to 1.32M | |
| 30-Jun-23 8:00 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 29-Jun-23 | Option Exercise | 232,000 | $1.60 | $371,200.00 | 23% 1.02M to 1.25M | |
| 30-Jun-23 8:00 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 28-Jun-23 | Option Sale | 268,000 | $7.98 | $2,139,310.00 | (21%) 1.29M to 1.02M | |
| 30-Jun-23 8:00 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 28-Jun-23 | Option Exercise | 268,000 | $1.60 | $428,800.00 | 26% 1.02M to 1.29M | |
| 27-May-22 8:30 PM View: | Skarpelos Athanasios Director | Anavex Life Sciences Corp. (AVXL) | 25-May-22 | Option Exercise | 50,000 | $0.92 | $46,000.00 | 4% 1.31M to 1.36M | |
| 27-May-22 8:30 PM View: | Skarpelos Athanasios Director | Anavex Life Sciences Corp. (AVXL) | 25-May-22 | Option Sale | 50,000 | $9.06 | $453,000.00 | (4%) 1.36M to 1.31M | |
| 25-May-21 9:30 PM View: | Favus Elliot Director | Anavex Life Sciences Corp. (AVXL) | 21-May-21 | Market Option Sale | 145,000 | $11.70 | $1,696,280.00 | (100%) 145.0K to 0 | |
| 25-May-21 9:30 PM View: | Favus Elliot Director | Anavex Life Sciences Corp. (AVXL) | 21-May-21 | Option Exercise | 145,000 | $1.94 | $280,820.00 | 100% 0 to 145.0K | |
| 19-May-21 8:47 AM View: | Donhauser Peter D.O. Director | Anavex Life Sciences Corp. (AVXL) | 17-May-21 | Market Purchase | 1,000 | $10.93 | $10,930.00 | 86% 1.17K to 2.17K | 4% |
| 26-Feb-21 9:31 PM View: | Favus Elliot Director | Anavex Life Sciences Corp. (AVXL) | 24-Feb-21 | Option Exercise | 145,500 | $3.06 | $445,390.00 | 100% 0 to 145.5K | |
| 26-Feb-21 9:31 PM View: | Favus Elliot Director | Anavex Life Sciences Corp. (AVXL) | 24-Feb-21 | Market Option Sale | 145,500 | $12.66 | $1,841,860.00 | (100%) 145.5K to 0 | |
| 23-Feb-21 1:22 PM View: | Donhauser Peter D.O. Director | Anavex Life Sciences Corp. (AVXL) | 19-Feb-21 | Market Purchase | 1,165 | $12.67 | $14,760.00 | 100% 0 to 1.17K | 2% |
| 09-Mar-18 3:16 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 07-Mar-18 | Market Purchase (Planned) | 1,360 | $2.92 | $3,971.20 | < 1% 1.02M to 1.02M | 106% |
| 07-Mar-18 11:01 AM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 06-Mar-18 | Market Purchase (Planned) | 1,450 | $2.73 | $3,958.50 | < 1% 1.02M to 1.02M | 121% |
| 06-Mar-18 2:06 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 05-Mar-18 | Market Purchase (Planned) | 1,500 | $2.63 | $3,945.00 | < 1% 1.01M to 1.02M | 129% |
| 05-Mar-18 8:56 AM View: | Missling Christopher U Director, President & CEO Director | Anavex Life Sciences Corp. (AVXL) | 02-Mar-18 | Market Purchase (Planned) | 1,650 | $2.41 | $3,976.50 | < 1% 1.01M to 1.01M | 150% |
| 26-Oct-17 2:49 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 25-Oct-17 | Market Purchase (Planned) | 375 | $4.39 | $1,646.25 | < 1% 1.01M to 1.01M | 38% |
| 24-Oct-17 12:05 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 24-Oct-17 | Market Purchase (Planned) | 375 | $4.92 | $1,845.00 | < 1% 1.01M to 1.01M | 23% |
| 19-Oct-17 6:46 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 19-Oct-17 | Market Purchase (Planned) | 375 | $4.49 | $1,683.75 | < 1% 1.01M to 1.01M | 34% |
| 18-Oct-17 9:46 AM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 17-Oct-17 | Market Purchase (Planned) | 375 | $4.27 | $1,601.25 | < 1% 1.01M to 1.01M | 41% |
| 16-Oct-17 11:06 AM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 13-Oct-17 | Market Purchase (Planned) | 750 | $4.22 | $3,165.00 | < 1% 1.01M to 1.01M | 43% |
| 05-Oct-17 5:56 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 05-Oct-17 | Market Purchase (Planned) | 375 | $4.30 | $1,612.50 | < 1% 1.01M to 1.01M | 40% |
| 02-Oct-17 7:52 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 02-Oct-17 | Market Purchase (Planned) | 375 | $4.20 | $1,575.00 | < 1% 1.01M to 1.01M | 44% |
| 29-Sep-17 2:31 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 28-Sep-17 | Market Purchase (Planned) | 375 | $4.21 | $1,578.75 | < 1% 1.01M to 1.01M | 43% |
| 26-Sep-17 3:07 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 26-Sep-17 | Market Purchase (Planned) | 375 | $3.88 | $1,455.00 | < 1% 1.01M to 1.01M | 56% |
| 20-Sep-17 4:50 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 20-Sep-17 | Market Purchase (Planned) | 375 | $4.23 | $1,586.25 | < 1% 1.01M to 1.01M | 43% |
| 19-Sep-17 1:58 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 18-Sep-17 | Market Purchase (Planned) | 375 | $4.40 | $1,650.00 | < 1% 1.01M to 1.01M | 37% |
| 14-Sep-17 2:27 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 14-Sep-17 | Market Purchase (Planned) | 375 | $4.58 | $1,717.50 | < 1% 1.01M to 1.01M | 32% |
| 11-Sep-17 8:49 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 11-Sep-17 | Market Purchase (Planned) | 375 | $4.81 | $1,803.75 | < 1% 1.01M to 1.01M | 26% |
| 08-Sep-17 7:20 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 07-Sep-17 | Market Purchase (Planned) | 375 | $4.76 | $1,785.00 | < 1% 1.01M to 1.01M | 27% |
| 05-Sep-17 2:20 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 05-Sep-17 | Market Purchase (Planned) | 375 | $4.90 | $1,837.50 | < 1% 1.01M to 1.01M | 23% |
| 31-Aug-17 2:45 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 31-Aug-17 | Market Purchase (Planned) | 375 | $4.48 | $1,680.00 | < 1% 1.01M to 1.01M | 35% |
| 29-Aug-17 11:12 AM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 28-Aug-17 | Market Purchase (Planned) | 375 | $4.44 | $1,665.00 | < 1% 1.01M to 1.01M | 36% |
| 25-Aug-17 2:18 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 24-Aug-17 | Market Purchase (Planned) | 375 | $4.54 | $1,702.50 | < 1% 1.01M to 1.01M | 33% |
| 21-Aug-17 11:42 AM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 21-Aug-17 | Market Purchase (Planned) | 375 | $4.07 | $1,526.25 | < 1% 1.0M to 1.01M | 48% |
| 18-Aug-17 4:54 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 18-Aug-17 | Market Purchase (Planned) | 375 | $3.81 | $1,428.75 | < 1% 1.0M to 1.0M | 58% |
| 14-Aug-17 5:12 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 14-Aug-17 | Market Purchase (Planned) | 375 | $3.70 | $1,387.50 | < 1% 1.0M to 1.0M | 63% |
| 11-Aug-17 4:35 PM View: | Missling Christopher U President and CEO Director | Anavex Life Sciences Corp. (AVXL) | 11-Aug-17 | Market Purchase (Planned) | 750 | $3.55 | $2,662.50 | < 1% 1.0M to 1.0M | 70% |
| 14-Jul-15 2:58 PM View: | Missling Christopher U President, CEO, CFO, Treasurer Director | Anavex Life Sciences Corp. (AVXL) | 14-Jul-15 | Market Purchase (Planned) | 1,000 | $0.52 | $518.40 | < 1% 4.01M to 4.01M | 190% |
| 14-Jul-15 2:44 PM View: | Missling Christopher U President, CEO, CFO, Treasurer Director | Anavex Life Sciences Corp. (AVXL) | 13-Jul-15 | Market Purchase (Planned) | 1,000 | $0.53 | $529.50 | < 1% 4.01M to 4.01M | 187% |
| 07-Jul-15 6:42 PM View: | Missling Christopher U President, CEO, CFO, Treasurer Director | Anavex Life Sciences Corp. (AVXL) | 07-Jul-15 | Market Purchase (Planned) | 1,000 | $0.51 | $509.90 | < 1% 4.01M to 4.01M | 198% |
| 07-Jul-15 6:42 PM View: | Missling Christopher U President, CEO, CFO, Treasurer Director | Anavex Life Sciences Corp. (AVXL) | 06-Jul-15 | Market Purchase (Planned) | 1,000 | $0.47 | $469.50 | < 1% 4.01M to 4.01M | 224% |
| 01-Jul-15 3:03 PM View: | Missling Christopher U President, CEO, CFO, Treasurer Director | Anavex Life Sciences Corp. (AVXL) | 01-Jul-15 | Market Purchase (Planned) | 1,000 | $0.45 | $454.80 | < 1% 3.01M to 3.01M | 233% |
| 01-Jul-15 3:03 PM View: | Missling Christopher U President, CEO, CFO, Treasurer Director | Anavex Life Sciences Corp. (AVXL) | 30-Jun-15 | Market Purchase (Planned) | 1,000 | $0.44 | $444.60 | < 1% 3.01M to 3.01M | 241% |
| 23-Jun-15 12:43 PM View: | Missling Christopher U President, CEO, CFO, Treasurer Director | Anavex Life Sciences Corp. (AVXL) | 23-Jun-15 | Market Purchase (Planned) | 1,000 | $0.47 | $468.00 | < 1% 3.01M to 3.01M | 230% |
| 22-Jun-15 6:15 PM View: | Missling Christopher U President, CEO, CFO, Treasurer Director | Anavex Life Sciences Corp. (AVXL) | 22-Jun-15 | Market Purchase (Planned) | 1,000 | $0.41 | $415.00 | < 1% 3.0M to 3.01M | 271% |
| 16-Jun-15 4:36 PM View: | Missling Christopher U President, CEO, CFO, Treasurer Director | Anavex Life Sciences Corp. (AVXL) | 16-Jun-15 | Market Purchase (Planned) | 1,000 | $0.44 | $442.00 | < 1% 3.0M to 3.0M | 249% |
